Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy colon, Biopsy skin, Computerised tomogram thorax, Expired product administered, Physical examination
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 010M20A and 025L20A) for COVID-19 vaccination.     The patient's past medical history included Chest wall pain, Bronchitis (Acute), Abdominal pain (Left lower quadrant), Urine analysis abnormal, Cardiac disorder (high risk) and Anticoagulant therapy. Previously administered products included for Product used for unknown indication: Influenza (Series 1) on 19-Oct-2018 and Influenza (Series 2) on 09-Nov-2020. Past adverse reactions to the above products included No adverse event with Influenza and Influenza. Concurrent medical conditions included Lung nodule, Lumbar strain (Left), Vitamin D deficiency, Liver cirrhosis (Nodules along the contour of the liver query.), Hematuria (Unspecified.), Nodule (Pulmonary Nodule, Right upper lobe 8mm.), Mitral insufficiency, Dysphagia (Intermittent), Atrial fibrillation (Paroxysmal), Impaired fasting glucose, Constipation, Reactive airways disease, Hearing loss, Supraventricular premature beats, Lung cancer, Gastroenteritis, Gastritis, Cellulitis, Sebaceous cyst, Colitis, Anal spasm, Anal fissure, External thrombosed hemorrhoids, Hyperlipidaemia, Cough, Sinusitis, Erectile dysfunction, Melanoma and Drug allergy (Mucinex(GUAIFENESIN)(Moderate)). Concomitant products included RIVAROXABAN (XARELTO) for Atrial fibrillation, HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) for Chest wall pain, HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) for Pain, METOPROLOL SUCCINATE for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy colon: results not reported Screen colon cancer. On an unknown date, Biopsy skin: results not reported Screen Skin cancer. On an unknown date, Computerised tomogram thorax: results not reported screen lung cancer. On an unknown date, Physical examination: normal (normal) routine. On an unknown date, Rectal examination: results not reported Screening for prostate cancer. On an unknown date, Urine analysis: abnormal (abnormal) abnormal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were reported  Date the vial was initially stored in the refrigerator 09-Nov-2021. The vial did not undergo any temperature excursions